Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin ▴	Return on equity	Revenue growth	Diluted EPS
TNXP	Tonix Pharmaceuticals Holding Corp. Manufacturing · Year ended 2025-12-31 · USD	$13.11M	-$124.02M	-946.2%	-50.6%	29.8%	-$14.57
NAMS	NewAmsterdam Pharma Co N.V. Manufacturing · Year ended 2025-12-31 · USD	$22.50M	-$203.82M	-905.7%	-29.8%	-50.6%	-$1.72
BIOA	BioAge Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$8.99M	-$80.61M	-896.1%	-29.6%	n/a	-$2.24
CYTK	Cytokinetics Inc Manufacturing · Year ended 2025-12-31 · USD	$88.04M	-$784.96M	-891.6%	n/a	376.6%	-$6.54
GOVX	GeoVax Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.49M	-$21.46M	-862.3%	-561.2%	-37.1%	n/a
ACRS	Aclaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.83M	-$64.92M	-829.6%	-63.0%	-58.2%	-$0.53
PRLD	Prelude Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$12.14M	-$99.50M	-819.6%	-145.0%	73.4%	-$1.29
CPMD	Cannapharmarx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.36M	-$11.13M	-817.2%	n/a	66.1%	-$0.02
AGIO	Agios Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.03M	-$412.78M	-764.0%	-34.6%	48.0%	-$7.12
SXTP	60 Degrees Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.01M	-$7.37M	-732.5%	-212.7%	65.5%	-$11.73
VSTM	Verastem, Inc. Manufacturing · Year ended 2025-12-31 · USD	$30.91M	-$209.47M	-677.6%	-366.2%	209.1%	-$3.02
CRVO	CervoMed Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.01M	-$26.97M	-673.1%	-148.0%	-58.9%	n/a
PYXS	Pyxis Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.86M	-$79.62M	-574.5%	-149.1%	-14.2%	-$1.28
TRDA	Entrada Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.42M	-$143.75M	-565.5%	-47.0%	-87.9%	-$3.47
IGC	IGC Pharma, Inc. Manufacturing · Year ended 2025-03-31 · USD	$1.27M	-$7.12M	-560.3%	-112.5%	-5.5%	-$0.09
SXTC	China SXT Pharmaceuticals, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.14M	-$6.21M	-545.2%	-20.9%	-34.6%	-$9.13
RGBP	Regen BioPharma Inc Manufacturing · Year ended 2025-09-30 · USD	$236.6K	-$1.27M	-538.8%	n/a	0.0%	-$0.05
EVMN	Evommune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.00M	-$68.87M	-529.8%	-33.5%	85.7%	-$11.22
OCUL	Ocular Therapeutix, Inc Manufacturing · Year ended 2025-12-31 · USD	$51.95M	-$265.94M	-511.9%	-40.6%	-18.5%	-$1.42
LPCN	Lipocine Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.98M	-$9.63M	-487.1%	-66.5%	-82.3%	-$1.69
VRDN	Viridian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.85M	-$342.60M	-483.6%	-47.4%	n/m	n/a
WVE	Wave Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$42.73M	-$204.38M	-478.3%	-39.4%	-60.5%	-$1.21
JAGX	Jaguar Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.51M	-$53.58M	-465.4%	n/a	-1.5%	-$22.97
BOLT	Bolt Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.70M	-$33.38M	-433.7%	-125.9%	0.1%	-$17.85
KURA	Kura Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$67.48M	-$278.67M	-412.9%	-160.0%	25.2%	-$3.18

Rows per page: 2550 100